GGrantIndex
Sort

326,823 grants matching clinical trial

SPORE in Skin Cancer

$2,195,541
Meenhard Herlyn · Wistar Institute · P50 · FY2008 · CA

TAS::75 0872::TAS SMARTT (11-8470187)

$2,195,479
Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · HL

Integration of Whole Genome Sequencing into Clinical Medicine

$2,195,445
Robert C. Green · Brigham And Women'S Hospital · U01 · FY2014 · HG

Combating Subclonal Evolution of Resistant Cancer Phenotypes

$2,195,349
Andrea Hope Bild · Beckman Research Institute/City Of Hope · U54 · FY2021 · CA

T Cell Costimulatory Pathways: Functions and Interactions

$2,194,909
Arlene H Sharpe · Harvard Medical School · P01 · FY2014 · AI

PHASE II TRIAL OF SLEEP APNEA TREATMENT TO REDUCE CARDIOVASCULAR MORBIDITY

$2,194,820
Susan S Redline · Brigham And Women'S Hospital · RC2 · FY2010 · HL

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$2,194,470
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19

$2,194,368
Carl H. June · University Of Pennsylvania · P01 · FY2021 · CA

IMMUNITY TO MELANOMA VIA DENDRITIC CELLS

$2,194,352
Baylor Research Institute · P01 · FY2000 · CA

SPORE in Skin Cancer

$2,194,229
Meenhard Herlyn · Wistar Institute · P50 · FY2022 · CA

Adeno-associated Virus Biology And Utilization For Gene Transfer

$2,194,150
Jay Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE

Coordinating Center to Help Eliminate/Reduce Oral health Inequalities in Children

$2,194,116
Stuart A Gansky · University Of California, San Francisco · U01 · FY2019 · DE

Alzheimer's Disease Research Center

$2,193,709
Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · AG

Multimodal MRI in Multiple Sclerosis

$2,193,641
Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS

Program Project in Models of Breast Cancer

$2,193,466
Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA

Futility Study of Deferoxamine Mesylate in Intracerebral Hemorrhage (Hi-DEF)

$2,193,084
Magdy H Selim · Beth Israel Deaconess Medical Center · U01 · FY2013 · NS

THERAPY OF AML

$2,192,972
University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA

Liver Cirrhosis Network: Scientific and Data Coordination Center

$2,192,940
Jody D. Ciolino · Northwestern University At Chicago · U24 · FY2024 · DK

THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)

$2,192,748
Fred Hutchinson Cancer Research Center · U01 · FY2003 · CA

MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM

$2,192,748
Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA

Integrative analysis and modeling of human immune responses and pathologies

$2,192,745
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

CANCER CENTER SUPPORT GRANT

$2,192,561
City Of Hope/Beckman Research Institute · P30 · FY2001 · CA

NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2023 - 02/29/2024. N01DA-22-2253. TASK ORDER 75N95023F00003 (TO7).

$2,192,292
Jennifer McCormack · The Emmes Company, Llc · N01 · FY2023 · DA

Center for Pre-Clinical Cancer Research

$2,192,025
Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2025 · GM

Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases

$2,191,844
Jiang He · Tulane University Of Louisiana · P20 · FY2020 · GM